Recent News

By Category: Countermeasures

BAA – Medical Countermeasures for Priority Pathogens

(Global Biodefense) The National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) to support development of therapeutic products for use in post-event settings following the intentional release or natural outbreak of high priority biological threats. Countermeasures are sought for Ebola and other filoviruses, Clostridium botulinum, Yersinia pestis, Francisella  Read More »

New Antibody Weapons Against Marburg Virus

(Global Biodefense) A new study led by scientists at The Scripps Research Institute identifies new immune molecules that protect against deadly Marburg virus, a relative of Ebola virus…The new antibodies that identify and neutralize Marburg virus – which has a mortality rate of up to 90% – were developed through an academic-industrial partnership including TSRI, Integrated  Read More »

FDA Accepts BLA for Inhalational Anthrax Countermeasure

(Global Biodefense) Anthim (obiltoxaximab) is for the treatment and prevention of inhalational anthrax, and is a candidate for future acquisition into the Strategic National Stockpile, the U.S. government’s repository of critical medical supplies for biowarfare preparedness.  Anthim has been developed under Fast-Track status and Orphan Drug Designation by the FDA.

South Korea MERS death toll rises to 20

(CNN) The World Health Organization said Tuesday that the number of new cases “appears to be declining” – indicating that the outbreak could be slowing down. But it also warned that “all outbreaks are unpredictable…especially for a comparatively new disease like MERS” where many facets of the virus are not well understood.

What you should know about MERS, the mystery disease that has South Korea on edge

(Washington Post) The spread of MERS, which has infected 126 people since the outbreak began last month, seems to have leveled off, and South Korean public health officials are urging calm. Still, Koreans remain wary of this new and little-understood illness. MERS first appeared in humans in 2012, and three years later scientists and public health officials are still sorting out where  Read More »